Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Higher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early November 30, 2017 3 Top Diabetes Biotechs to Buy Into Right Now November 26, 2017 Billionaire Insys Founder Charged With Bribing Doctors to Prescribe Opioid Painkillers October 26, 2017
Billionaire Insys Founder Charged With Bribing Doctors to Prescribe Opioid Painkillers October 26, 2017
